Clinical Trial Update: Efficacy Study on Early Versus Late Abciximab Administration During Primary Coronary Angioplasty [Phase 4]

View source ↗

Summary

Phase 4 study assessing early versus late abciximab administration during primary percutaneous coronary intervention in patients with myocardial infarction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Abciximab (abciximab)

Snippet

Sponsor: University of Pisa | Conditions: Myocardial Infarction | Phase 4 | Status: COMPLETED